Key facts
- GasGene’s last known valuation is $13.8M (Oct 2023).
- It has raised $20.0M; the latest was Early Stage VC ($14.5M) in Feb 2026.
- Notable investors include Qianhai FoF, Zijin Hi-Tech Venture Capital, Tencent Investment, Tianjin Venture Capital, Jiangbei Investment Group — 11 tracked in total.
- Status: Privately Held (backing).
Investors
11+- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for GasGene
- ·The full record, as it builds
Funding rounds
No funding rounds for GasGene are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About GasGene
Manufacturer of synthetic biology products designed to transform carbon utilisation and support sustainable industry. The company's offerings feature engineered Clostridia and anaerobic gas-fermentation technology, enabling customers to benefit from cost-efficient, carbon-negative chemical and protein production, which supports progress toward energy security and carbon neutrality.
- Sector
- Materials and Resources
- HQ
- Nanjing, China
- Founded
- 2023
- Website
- gasgene.com.cn/
- Ownership
- Privately Held (backing)
GasGene doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GasGene shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GasGene in its N-PORT filings yet. We sweep new filings monthly.